Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 3 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar 1badbeerad (44.71) Submitted: 7/20/2013 10:56:39 PM : Outperform Start Price: $6.93 ARNA Score: -2.32

Should perform

Featured Broker Partners


Advertisement